Status:

COMPLETED

Efficacy of Online Hemodiafiltrationlysis in Cytokine Removal

Lead Sponsor:

Chulalongkorn University

Conditions:

Sepsis

Acute Kidney Injury

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Following the concept of "peak concentration hypothesis", which suggest the cutting peak of pro- and anti-inflammatory mediators would result in restoring a situation of immunohomeostasis. The investi...

Detailed Description

1. Blood samples were taken from patients before and at the end of 4-hour in the first dialysis session. The percentage of reductions were calculated from the before and ending samples. The values of ...

Eligibility Criteria

Inclusion

  • Sepsis
  • acute kidney injury (RIFLE classification F)
  • Age more than 18

Exclusion

  • Hemodynamic instability
  • Whom written informed consent could not be obtained

Key Trial Info

Start Date :

January 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2011

Estimated Enrollment :

28 Patients enrolled

Trial Details

Trial ID

NCT01791712

Start Date

January 1 2010

End Date

October 1 2011

Last Update

February 15 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

King Chulalongkorn Memorial Hospital

Bangkok, Bangkok, Thailand, 10330

Efficacy of Online Hemodiafiltrationlysis in Cytokine Removal | DecenTrialz